Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $145,480 - $167,380
1,000 New
1,000 $162,000
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $74,317 - $79,718
-466 Reduced 82.33%
100 $11,000
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $292,592 - $335,848
-2,134 Reduced 79.04%
566 $238,000
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $364,988 - $399,958
2,600 Added 2600.0%
2,700 $11,000
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $167,453 - $202,163
-1,300 Reduced 92.86%
100 $8,000
Q2 2019

Aug 13, 2019

BUY
$131.15 - $144.24 $183,610 - $201,936
1,400 New
1,400 $3,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.